Lv21
110 积分 2024-01-20 加入
Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study
1个月前
已完结
Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study
1个月前
已完结
Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial
2个月前
已完结
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL
2个月前
已关闭
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL
2个月前
已关闭
Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated by Gemcitabine-based Chemotherapy
2个月前
已完结
Treatment duration of adjuvant immune checkpoint inhibitors in hepatocellular carcinoma patients at high risk of recurrence after resection: A prospective, multicentric cohort study
4个月前
已完结
Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial
4个月前
已完结
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
8个月前
已完结
Immunotherapy at all stages of hepatocellular carcinoma
8个月前
已完结
皖公网安备34019202002308
